Vol 17, No 3 (2014)

Table of Contents

Review Articles

Applications of Polymeric and Lipid Nanoparticles in Ophthalmic Pharmaceutical Formulations: Present and Future Considerations Abstract PDF
Hugo Almeida, Maria Helena Amaral, Paulo Lobão, Ana C Silva, José Manuel Sousa Loboa 278-293
Safety of Anti-Tumor Necrosis Factor Therapies in Arthritis Patients Abstract PDF
Radu M Nanau, Manuela G Neuman 324-361
Targeting the C-type Lectins-Mediated Host-Pathogen Interactions with Dextran Abstract PDF
Sergey Pustylnikov, Divya Sagar, Pooja Jain, Zafar K Khan 371-392
Liposomal Drug Delivery: A Versatile Platform for Challenging Clinical Applications Abstract PDF
Asadullah Madni, Muhammad Sarfraz, Mubashar Rehman, Mahmood Ahmad, Naveed Akhtar, Saeed Ahmad, Nayab Tahir, Shakeel Ijaz, Raida Al-Kassas, Raimar Löbenberg 401-426

Pharmaceutical Sciences Original Articles

Cytochrome P450 3A4 and 2D6-Mediated Metabolism of Leisure and Medicinal Teas Abstract PDF
Teresa W Tam, Rui Liu, Ammar Saleem, John Thor Arnason, Anthony Krantis, Brian C Foster 294-301
Herb-drug Pharmacokinetic Interaction between Carica Papaya Extract and Amiodarone in Rats Abstract PDF
Márcio Rodrigues, Gilberto Alves, Joana Francisco, Ana Fortuna, Amílcar Falcão 302-315
Effects of PDE4 Pathway Inhibition in Rat Experimental Stroke Abstract PDF
Fan Yang, Rachita K Sumbria, Dong Xue, Chuanhui Yu, Dan He, Shuo Liu, Annlia Paganini-Hill, Mark Fisher 362-370
Tacrine Sinusoidal Uptake and Biliary Excretion in Sandwich-Cultured Primary Rat Hepatocytes Abstract PDF
Amal Kaddoumi, Loqman A. Mohamed 427-438

Reports

Use of Proton Pump Inhibitors as Adjunct Treatment for Triple-Negative Breast Cancers. An Introductory Study Abstract PDF
Wayne Goh, Inna Sleptsova-Freidrich, Nenad Petrovic 439-446

Clinical Pharmacology and Therapeutics

Evaluation of the Efficacy and Safety of Changes in Antiretroviral Regimens for HIV-infected Patients Abstract PDF
Hiroyuki Tanaka, Tatsuhiko Wada, Yoko Takayama, Keisuke Matsumoto, Koichiro Atsuda, Mitsutoshi Satoh 316-323
Clinical Trial Risk in Type-2 Diabetes: Importance of Patient History Abstract PDF
Emmanuel O. Aiyere, Jay Silverberg, Safina Ali, Jayson L. Parker 393-400


ISSN: 1482-1826